Search

everythinglearnresearchcommunity

for

Search:↓

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

New therapies targeting skin neuroimmune interactions could treat neuropathic pain.

Nociplastic pain is a complex, heritable trait with genetic links to chronic and neuropathic pain.

The conference discussed various hair disorders and treatments, including the use of topical steroids, high doses of cetrizine, and hair grafting, as well as the psychological impact of hair loss.

Progesterone initially worsens but later reduces neuropathic pain in mice, through different mechanisms.

Curcumin shows promise in reducing pain and inflammation, but more research is needed.

Botulinum toxin is effectively used to treat various painful conditions and its therapeutic uses are growing.

Compression therapy improved ankle movement, reduced leg swelling, and lessened pain in patients with venous leg ulcers.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

A man's severe head pain after hair transplant was greatly relieved by pulsed radiofrequency treatment.

Lysophosphatidic acid affects sensory neurons and may cause neuropathic pain and itch.

Regenerative medicine may offer long-lasting relief for chronic pain and neuro-degenerative conditions.

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

Procyanidins from grape seeds reduce nerve pain by blocking specific proteins and inflammation.

Cernitin™, a pollen extract, was found to significantly reduce pain and inflammation in rats with chronic prostatitis, suggesting it could be a useful alternative to certain anti-inflammatory drugs.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Machine learning can predict symptoms and quality of life in chronic skin disease patients using smartphone app data, and shows that app use varies with patient characteristics.

Standardizing PRP preparation and application could improve its effectiveness for chronic pain relief.

Testosterone therapy can improve hormone levels and quality of life in men with morphine-induced hormone issues.

Regenerative medicine may help reduce radiotherapy side effects like skin cancer, fibrosis, pain, and hair loss.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Antidepressants may improve or resolve scalp dysesthesia in most patients.

Using platelet-rich plasma and fat grafting to treat nerve pain showed promising results with no side effects.

Photobiomodulation is safe and effective for treating certain conditions like nerve pain and hair loss.

Recognizing and managing central sensitization and stress is crucial for treating chronic pain.

Neuropathic pruritus is a commonly overlooked and wrongly diagnosed type of chronic itching that is hard to treat.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

Psychiatrists are crucial in pain management teams because they help treat severe pain and related mental health issues.

Exosome therapy may help treat diabetic nerve damage, but more research is needed.

The consensus document recommends a comprehensive treatment plan for Hidradenitis Suppurativa, including various medications, surgery, lifestyle changes, and the need for more research and resources.